According to Spyre Therapeutics's latest financial reports the company's total assets are โฌ0.41 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | โฌ0.30 B | 366.27% |
2022-12-31 | โฌ66.32 M | -31.67% |
2021-12-31 | โฌ97.06 M | -26.13% |
2020-12-31 | โฌ0.13 B | 76.95% |
2019-12-31 | โฌ74.25 M | 9.27% |
2018-12-31 | โฌ67.95 M | 45.4% |
2017-12-31 | โฌ46.73 M | -26.7% |
2016-12-31 | โฌ63.75 M | 80.35% |
2015-12-31 | โฌ35.35 M | 1367.42% |
2014-12-31 | โฌ2.4 M | -27.63% |
2013-12-31 | โฌ3.32 M |